Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hermans

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 9, 2011
Exercise related ventricular arrhythmias are related to cardiac fibrosis in hypertrophic cardiomyopathy mutation carriersI A W van Rijsingen, S C A M Bekkers, S Schalla, et al.
Clinical & Translational Immunology|July 7, 2022
Glycolipid-peptide conjugate vaccines elicit CD8<sup>+</sup> T-cell responses and prevent breast cancer metastasisOlivia K Burn, Kathryn Farrand, Tara Pritchard, et al.
Oncoimmunology|June 17, 2022
Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effectKef K Prasit, Laura Ferrer-Font, Olivia K Burn, et al.
Journal for Immunotherapy of Cancer|April 17, 2024
Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanomaFlorian Hornsteiner, Janine Vierthaler, Helen Strandt, et al.
European Heart Journal|December 19, 2009
The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screeningImke Christiaans, Erwin Birnie, Irene M van Langen, et al.
Cancer Immunology, Immunotherapy : CII|November 3, 2017
A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patientsOlivier Gasser, Katrina J Sharples, Catherine Barrow, et al.
Haematologica|March 26, 2026
Treatment of therapy-related acute myeloid leukemia and acute myeloid leukemia with myelodysplasia-related changes: a comparative analysis of higher-dose intensive 7+3 induction chemotherapy <i>versus</i> liposomal cytarabine and daunorubicinDimitrios Kotsos, Patrycja Gradowska, Sjoerd J F Hermans, et al.
Cell Reports|March 29, 2023
MAIT cells activate dendritic cells to promote T<sub>FH</sub> cell differentiation and induce humoral immunityTheresa E Pankhurst, Kaitlin H Buick, Joshua L Lange, et al.
Journal of the American College of Cardiology|January 28, 2012
Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort studyIngrid A W van Rijsingen, Eloisa Arbustini, Perry M Elliott, et al.
ACS Chemical Biology|October 19, 2017
Augmenting Influenza-Specific T Cell Memory Generation with a Natural Killer T Cell-Dependent Glycolipid-Peptide VaccineRegan J Anderson, Jasmine Li, Lukasz Kedzierski, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 9, 2011
Exercise related ventricular arrhythmias are related to cardiac fibrosis in hypertrophic cardiomyopathy mutation carriersI A W van Rijsingen, S C A M Bekkers, S Schalla, et al.
Clinical & Translational Immunology|July 7, 2022
Glycolipid-peptide conjugate vaccines elicit CD8<sup>+</sup> T-cell responses and prevent breast cancer metastasisOlivia K Burn, Kathryn Farrand, Tara Pritchard, et al.
Oncoimmunology|June 17, 2022
Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effectKef K Prasit, Laura Ferrer-Font, Olivia K Burn, et al.
Journal for Immunotherapy of Cancer|April 17, 2024
Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanomaFlorian Hornsteiner, Janine Vierthaler, Helen Strandt, et al.
European Heart Journal|December 19, 2009
The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screeningImke Christiaans, Erwin Birnie, Irene M van Langen, et al.
Cancer Immunology, Immunotherapy : CII|November 3, 2017
A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patientsOlivier Gasser, Katrina J Sharples, Catherine Barrow, et al.
Haematologica|March 26, 2026
Treatment of therapy-related acute myeloid leukemia and acute myeloid leukemia with myelodysplasia-related changes: a comparative analysis of higher-dose intensive 7+3 induction chemotherapy <i>versus</i> liposomal cytarabine and daunorubicinDimitrios Kotsos, Patrycja Gradowska, Sjoerd J F Hermans, et al.
Cell Reports|March 29, 2023
MAIT cells activate dendritic cells to promote T<sub>FH</sub> cell differentiation and induce humoral immunityTheresa E Pankhurst, Kaitlin H Buick, Joshua L Lange, et al.
Journal of the American College of Cardiology|January 28, 2012
Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort studyIngrid A W van Rijsingen, Eloisa Arbustini, Perry M Elliott, et al.
ACS Chemical Biology|October 19, 2017
Augmenting Influenza-Specific T Cell Memory Generation with a Natural Killer T Cell-Dependent Glycolipid-Peptide VaccineRegan J Anderson, Jasmine Li, Lukasz Kedzierski, et al.
Pageof 13